Inventor · disambiguated record
Eric Jon Jacobsen
Also filed as: JACOBSEN ERIC J · JACOBSEN ERIC JOHN · JACOBSEN ERIC JON
45 granted patents·19 pending applications·881 citations·filing 1994–2023
98Inventor score
Files withPFIZER19UPJOHN CO19ACLARIS THERAPEUTICS INC14CONFLUENCE LIFE SCIENCES INC4PHARMACIA & UPJOHN CO LLC1
Top patents by PatentIndex Score
64 records- 0196US10981906B2Substituted pyrrolopyridine JAK inhibitors and methods of making and using the sameACLARIS THERAPEUTICS INC·Filed 2018·Granted Apr 20, 2021·9 cites·21 claims
- 0296US6407092B1Tetracyclic azepinoindole compoundsUPJOHN CO·Filed 2000·Granted Jun 18, 2002·110 cites·38 claims
- 0395US6919359B2Azabicyclic-substituted-heteroaryl compounds for the treatment of diseasePFIZER·Filed 2002·Granted Jul 19, 2005·61 cites·23 claims
- 0495US6492385B2Quinuclidine-substituted heteroaryl moieties for treatment of diseaseUPJOHN CO·Filed 2001·Granted Dec 10, 2002·70 cites·97 claims
- 0594US11739086B2Substituted pyrrolopyridine JAK inhibitors and methods of making and using the sameACLARIS THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·4 cites·5 claims
- 0694US10800775B2Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the sameACLARIS THERAPEUTICS INC·Filed 2018·Granted Oct 13, 2020·8 cites·20 claims
- 0794US9695200B2Heterocyclic ITK inhibitors for treating inflammation and cancerCONFLUENCE LIFE SCIENCES INC·Filed 2016·Granted Jul 4, 2017·19 cites·7 claims
- 0894US6911543B2Azabicyclic-substituted fused-heteroaryl compounds for the treatment of diseasePFIZER·Filed 2002·Granted Jun 28, 2005·71 cites·15 claims
- 0993US7001900B2Azabicyclic compounds for the treatment of diseasePFIZER·Filed 2003·Granted Feb 21, 2006·74 cites·5 claims
- 1093US6849620B2N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of diseasePFIZER·Filed 2002·Granted Feb 1, 2005·48 cites·31 claims
- 1192US11820775B2Pyrrolopyrimidine ITK inhibitorsACLARIS THERAPEUTICS INC·Filed 2021·Granted Nov 21, 2023·2 cites·34 claims
- 1292US6500840B2Quinuclidine-substituted heteroaryl moieties for treatment of diseaseUPJOHN CO·Filed 2001·Granted Dec 31, 2002·66 cites·52 claims
- 1391US6828314B2Substituted azepino[4,5b]indoline derivativesPFIZER·Filed 2003·Granted Dec 7, 2004·38 cites·12 claims
- 1491US6599916B2Quinuclidine-substituted heteroaryl moieties for treatment of diseaseUPJOHN CO·Filed 2001·Granted Jul 29, 2003·53 cites·52 claims
- 1590US12281111B2Substituted pyrrolopyridine JAK inhibitors and methods of making and using the sameACLARIS THERAPEUTICS INC·Filed 2023·Granted Apr 22, 2025·1 cites·7 claims
- 1689US8633206B2Pyrrolo[2,3-D]pyrimidine compoundsPROMO MICHELE ANN·Filed 2010·Granted Jan 21, 2014·28 cites·28 claims
- 1786US5804593Aα-Amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitorsUPJOHN CO·Filed 1997·Granted Sep 8, 1998·71 cites·11 claims
- 1885US12297203B2Pyrrolopyrimidine ITK inhibitorsACLARIS THERAPEUTICS INC·Filed 2023·Granted May 13, 2025·0 cites·5 claims
- 1985US6562816B2Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of diseaseUPJOHN CO·Filed 2002·Granted May 13, 2003·26 cites·32 claims
- 2083US6875762B2Tetracyclic azepinoindole compoundsPFIZER·Filed 2003·Granted Apr 5, 2005·15 cites·28 claims
- 2182US11021482B2Pyrrolopyrimidine ITK inhibitorsACLARIS THERAPEUTICS INC·Filed 2019·Granted Jun 1, 2021·2 cites·21 claims
- 2282US9145393B2Arylpyridinone ITK inhibitors for treating inflammation and cancerCONFLUENCE LIFE SCIENCES INC·Filed 2015·Granted Sep 29, 2015·2 cites·17 claims
- 2381US9499551B2Substituted pyrrolo[2,3-b]pyridines for treating cancer or inflammatory diseasesCONFLUENCE LIFE SCIENCES INC·Filed 2015·Granted Nov 22, 2016·4 cites·10 claims
- 2479US6951868B2Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of diseasePFIZER·Filed 2002·Granted Oct 4, 2005·14 cites·34 claims
- 2579US6894042B2Azabicyclic compounds for the treatment of diseaseUPJOHN CO·Filed 2003·Granted May 17, 2005·12 cites·14 claims
- 2677US7176198B21H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of diseasePFIZER·Filed 2003·Granted Feb 13, 2007·9 cites·11 claims
- 2776US5847148AThiadiazole derivatives useful for the treatment of diseases related to connective tissue degradationUPJOHN CO·Filed 1997·Granted Dec 8, 1998·22 cites·15 claims
- 2875US8372854B2Pyrrolo[2,3-D]pyrimidine compoundsPFIZER·Filed 2010·Granted Feb 12, 2013·3 cites·26 claims
- 2975US6579870B2Bis-arylsulfonesUPJOHN CO·Filed 2001·Granted Jun 17, 2003·8 cites·49 claims
- 3073US6903090B2Substituted azepino[4,5b]indole derivativesPFIZER·Filed 2003·Granted Jun 7, 2005·5 cites·21 claims
- 3173US6586421B2Substituted azepino[4,5b]indoline derivativesUPJOHN CO·Filed 2001·Granted Jul 1, 2003·5 cites·11 claims
- 3272US6858613B2Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of diseasePFIZER·Filed 2003·Granted Feb 22, 2005·5 cites·5 claims
- 3372US6852716B2Substituted-aryl compounds for treatment of diseasePFIZER·Filed 2003·Granted Feb 8, 2005·6 cites·12 claims
- 3468US6468999B11,2,3,4,5,6,-hexahydroazepino [4,5-b]indoles containing arylsulfones at the 9-positionUPJOHN CO·Filed 2000·Granted Oct 22, 2002·6 cites·24 claims
- 3566US2022372034A1Substituted pyrrolopyridines as jak inhibitorsACLARIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3664US6583135B2Substituted azepino[4,5b]indole derivativesUPJOHN CO·Filed 2001·Granted Jun 24, 2003·1 cites·9 claims
- 3759US2019352300A1Pyrrolopyrimidine itk inhibitors for treating inflammation and cancerACLARIS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3858US10316038B2Pyrrolopyrimidine ITK inhibitors for treating inflammation and cancerACLARIS THERAPEUTICS INC·Filed 2018·Granted Jun 11, 2019·0 cites·27 claims
- 3958US2024002380A1Rev-erb agonistsUNIV SAINT LOUIS·Filed 2023·Application pending·0 cites
- 4057US11420966B2Substituted pyrrolopyridines as JAK inhibitorsACLARIS THERAPEUTICS INC·Filed 2020·Granted Aug 23, 2022·0 cites·17 claims
- 4157US2005282796A1Tetracyclic azepinoindole compoundsPFIZER·Filed 2005·Application pending·0 cites
- 4257US2019106439A1Heterocyclic itk inhibitors for treating inflammation and cancerACLARIS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4354US10150783B2Heterocyclic ITK inhibitors for treating inflammation and cancerACLARIS THERAPEUTICS INC·Filed 2017·Granted Dec 11, 2018·0 cites·21 claims
- 4454US2005215584A1Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of diseasePFIZER·Filed 2004·Application pending·0 cites
- 4554US2005222196A1Azabicyclic-substituted fused heteroaryl compounds for the treatment of diseasePFIZER·Filed 2005·Application pending·0 cites
- 4654US2005234092A1Azabicyclic-substituted fused heteroaryl compounds for the treatment of diseasePFIZER·Filed 2005·Application pending·0 cites
- 4753US2004224976A1Azabicyclic compounds for the treatment of diseaseFiled 2004·Application pending·0 cites
- 4852US2002198190A1Tetracyclic azepinoindole compoundsUPJOHN CO·Filed 2002·Application pending·0 cites
- 4952US2006116395A11H-pyrazole and 1h-pyrole-azabicyclic compounds for the treatment of diseasePFIZER·Filed 2006·Application pending·0 cites
- 5051US2022235043A1Substituted sulfonamide pyrrolopyridines as jak inhibitorsACLARIS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Eric Jon Jacobsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →